REQUEST A DEMO
Total
USD $0.00
Search more companies

Alvogen Pharma Trading Europe EOOD (Bulgaria)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Alvogen Pharma Trading Europe EOOD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Alvogen Pharma Trading Europe EOOD was established in 2010. The company is active in the wholesale distribution and marketing of generic pharmaceutical products. It operates representative offices in Russia and Kazakhstan.

Headquarters
Manastirski Livadi District, 86 Bulgaria Blvd.
Sofia; Sofia - city; Postal Code: 1680

Contact Details: Purchase the Alvogen Pharma Trading Europe EOOD report to view the information.

Website: http://www.alvogen.com/

Basic Information
Total Employees:
Purchase the Alvogen Pharma Trading Europe EOOD report to view the information.
Outstanding Shares:
Purchase the Alvogen Pharma Trading Europe EOOD report to view the information.
Registered Capital:
Purchase the Alvogen Pharma Trading Europe EOOD report to view the information.
Financial Auditors:
Purchase the Alvogen Pharma Trading Europe EOOD report to view the information.
Incorporation Date:
2011
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Alvogen Pharma Trading Europe EOOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
-4%
Total operating revenue
-4%
Operating profit (EBIT)
5.18%
EBITDA
10.19%
Net Profit (Loss) for the Period
N/A
Total assets
-11.67%
Total equity
68.89%
Operating Profit Margin (ROS)
0.86%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
1.38%
Quick Ratio
0.13%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?